Here's What Key Metrics Tell Us About Alkermes (ALKS) Q1 EarningsZacks Investment Research • 05/01/25
New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)PRNewsWire • 04/30/25
Alkermes to Participate in the 24th Annual Needham Virtual Healthcare ConferencePRNewsWire • 04/02/25
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic HypersomniaPRNewsWire • 04/01/25
New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I DisorderPRNewsWire • 03/27/25
Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition?Zacks Investment Research • 03/25/25
GE Aerospace Leads Five Stocks Near Buy Points With This Bullish TraitInvestors Business Daily • 03/22/25
Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy PointsInvestors Business Daily • 03/17/25
Alkermes' Neuroscience Pivot: ALKS 2680 Set To Revolutionize Narcolepsy TreatmentSeeking Alpha • 02/25/25
Alkermes (ALKS) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/12/25
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025PRNewsWire • 02/12/25
What Analyst Projections for Key Metrics Reveal About Alkermes (ALKS) Q4 EarningsZacks Investment Research • 02/10/25
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025PRNewsWire • 02/05/25